An observational study in Polyendocrine Metabolic Ovarian Syndrome and Acne Vulgaris, sponsored by Sohag University. Recruiting at 1 site in Egypt. Open to female participants aged 15 Years to 49 Years. Per ClinicalTrials.gov, last updated 2026-09-16.
Sponsored by Sohag University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Acne Vulgaris with a site in Egypt — 10 open to participants now, 11 under way, 2 of them phase 3. Acne Vulgaris · Egypt.
Among the 39 studies in Acne Vulgaris with a site in Egypt, this one is one of 4 that started in 2026, is one of 8 observational ones, reaches primary completion later than 8 of the 10 other live ones, and was the 37th registered.
791 studies on the registry are indexed under Acne Vulgaris; 94 are open to participants now.
Browse Acne Vulgaris studies →10 of the 39 studies in Acne Vulgaris with a site in Egypt are open now. Recruiting first, the newest first:
Aswan University · Sites in Egypt
Ages 18–40 · Healthy volunteers
Assiut University · Sites in Egypt
Ages 12–35
Venus Research Center · Sites in Egypt
Tanta University · Sites in Egypt
Ages 18+
Cairo University · Sites in Egypt
Ages 18–45
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 47 Acne Vulgaris studies recruiting now, 17 (36%) set no upper age limit and 29 (62%) stop at 75 or younger; 21 take children under 18; 17 take healthy volunteers.
This study: 15 Years to 49 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 4 · Phase 4 4
First in 2016; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is close to the median of 88 across 95 observational studies indexed under Acne Vulgaris.
Median enrollment 60 across the 31 interventional studies, 84 across the 8 observational. Of the 22 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 39 has an industry lead sponsor. The 10 most frequent:
Sohag University is the lead sponsor of 1,232 studies on the registry; 638 are open to participants now.
Sohag University has 9 studies filed under Acne Vulgaris — fewer than ten, so there is no comparison to draw.
3 of the studies in Acne Vulgaris with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07919886Phase 3Cairo UniversityEvaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris. | 2027-05-20 |
| NCT07822360Sohag UniversityPrevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital | 2027-02-08 |
| NCT07296523Venus Research CenterExpert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study | 2027-06-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 39 studies in Acne Vulgaris with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to determine the prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among female patients diagnosed with acne vulgaris in Sohag university hospital
A cross-sectional observational study designed to determine the prevalence of polycystic ovary syndrome (PCOS) among patients diagnosed with acne vulgaris attending Sohag University Hospital.
Female patients diagnosed with acne vulgaris
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients clinically diagnosed with acne vulgaris.
o Presence of comedones (open/black and closed/white), inflammatory lesions (papules, pustules, or nodules), with or without post-acne changes such as hyperpigmentation or scarring (Oge et al., 2019).
Diagnostic criteria for PMOS diagnosis in adults : (Forslund et al., 2024).
Diagnosis of PMOS will be based on the presence of at least two of the following three criteria after exclusion of other etiologies:
1. Ovulatory dysfunction:
Clinical signs such as hirsutism and/or acne, or biochemical evidence of elevated androgen levels.
3. Polycystic ovarian morphology (PCOM):
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among patients diagnosed with acne vulgaris in Sohag university hospital
Time frame: Over 1 year
Plan to share: Undecided
Started Aug 2026 (actual). Primary completion is estimated for Feb 2027, 5 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.